Retinoic acid regulates arterial smooth muscle cell proliferation and phenotypic features in vivo and in vitro through an RARα-dependent signaling pathway

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 19, Issue 6, 1999, Pages 1430-1436

  Neuville, P ^c   Yan, Z Q ^a   Gidlof A ^a   Pepper, M S ^c   Hansson, G K ^a   Gabbiani, G ^b   Sirsjo A ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF GENEVA   (Switzerland)

^c NONE

Author keywords

Intimal thickening; Smooth muscle cell differentiation; Smooth muscle cell heterogeneity; Smooth muscle cell motility

Indexed keywords

RETINOIC ACID; RETINOIC ACID RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA MEDIA; ARTERY ENDOTHELIUM; ARTERY INJURY; ARTERY INTIMA PROLIFERATION; ARTERY MUSCLE; ARTICLE; CAROTID ARTERY DISEASE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFECT; DRUG SCREENING; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION;

EID: 0032983857     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.19.6.1430     Document Type: Article

References (53)

1. Ross R. Cell biology of atherosclerosis. Annu Rev Physiol. 1995;57: 791-804.
2. Schwartz SM, deBlois D, O'Brien ERM. The intima: soil for atherosclerosis and restenosis. Circ Res. 1995;77:445-465.
3. Shanahan CM, Weissberg PL. Smooth muscle cell heterogeneity: patterns of gene expression in vascular smooth muscle cells in vitro and in vivo. Arterioscler Thromb Vasc Biol. 1998;18:333-338.
4. Seidel CL. Cellular heterogeneity of the vascular tunica media: implications for vessel wall repair. Arterioscler Thromb Vasc Biol. 1997;17: 1868-1871.
5. Orlandi O, Ehrlich HP, Ropraz P, Spagnoli LG, Gabbiani G. Rat aortic smooth muscle cells isolated from different layers and at different times after endothelial denudation show distinct biological features in vitro. Arterioscler Thromb. 1994;14:982-989.
6. Bochaton-Piallat M-L, Ropraz P, Gabbiani F, Gabbiani G. Phenotypic heterogeneity of rat arterial smooth muscle cell clones. Implications for the development of experimental intimal thickening. Arterioscler Thromb Vasc Biol. 1996;16:815-820.
7. Orlandi A, Ropraz P, Gabbiani G. Proliferative activity and alpha-smooth muscle actin expression in cultured rat aortic smooth muscle cells are differently modulated by transforming growth factor-beta1 and heparin. Exp Cell Res. 1994;214:528-536.
8. Sartore S, Chiavegato A, Franch R, Faggin E, Pauletto P. Myosin gene expression and cell phenotype in vascular smooth muscle during development, in experimental models, and in vascular disease. Arterioscler Thromb Vasc Biol. 1997;17:1210-1215.
9. Schwartz SM. Smooth muscle migration in atherosclerosis and restenosis. J Clin Invest. 1997;100:S87-S89.
10. Zile MH. Vitamin A and embryonic development: an overview. J Nutr. 1998;128:455S-458S.
11. Chambon P. The retinoid signaling pathway: molecular and genetic analyses. Semin Cell Biol. 1994;5:115-125.
12. Cremona O, Muda M, Appel RD, Frutiger S, Hughes GJ, Hochstrasser DF, Geinoz A, Gabbiani G. Differential protein expression in aortic smooth muscle cells cultured from newborn and aged rats. Exp Cell Res. 1995;217:280-287.
13. Neuville P, Geinoz A, Benzonana G, Redard M, Gabbiani F, Ropraz P, Gabbiani G. Cellular retinol-binding protein I is expressed by distinct subsets of rat arterial smooth muscle cells in vitro and in vivo. Am J Pathol. 1997;150:509-521.
14. Baumgartner HR, Studer A. Folgen des Gefässkatheterismus am normound hypercholesterinaemischen Kaninchen. Pathol Microbiol. 1966;29: 393-405.
15. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970;227:680-685.
16. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248-254.
17. Skalli O, Ropraz P, Trzeciak A, Benzonana G, Gillessn D, Gabbiani G. A monoclonal antibody against α-smooth muscle actin: a new probe for smooth muscle differentiation. J Cell Biol. 1986;103:2787-2796.
18. Gabbiani G, Gabbiani F, Heimark RL, Schwartz SM. Organization of actin cytoskeleton during early endothelial regeneration in vitro. J Cell Sci. 1984;66:39-50.
19. Pepper MS, Belin D, Montesano R, Orci L, Vassalli JD. Transforming growth factor-β1 modulates basic fibroblast growth factor-induced proteolytic and angiogenic properties of endothelial cells in vitro. J Cell Biol. 1990;111:743-755.
20. Bochaton-Piallat ML, Gabbiani G, Pepper MS. Plasminogen activator expression in rat arterial smooth muscle cells depends on their phenotype and is modulated by cytokines. Circ Res. 1998;82:1086-1093.
21. De Luca LM, Darwiche N, Jones CS, Scita G. Retinoids in differentiation and neoplasia. Sci Med. 1995;2:28-37.
22. Futoryan T, Gilchrest BA. Retinoids and the skin. Nutr Rev. 1994;52: 299-310.
23. Hong WK, Sporn MB. Recent advances in chemoprevention of cancer. Science. 1997;278:1073-1077.
24. Peclo MM, Printseva OY. Retinoic acid enhances the proliferation of smooth muscle cells. Experientia. 1987;43:196-198.
25. Miano JM, Topouzis S, Majesky MW, Olson EN. Retinoid receptor expression and all-wins retinoic acid-mediated growth inhibition in vascular smooth muscle cells. Circulation. 1996;93:1886-1895.
26. Chen S, Gardner DG. Retinoic acid uses divergent mechanisms to activate or suppress mitogenesis in rat aortic smooth muscle cells. J Clin Invest. 1998;102:653-662.
27. Takatsuka J, Takahashi N, De Luca LM. Retinoic acid metabolism and inhibition of cell proliferation: an unexpected liaison. Cancer Res. 1996; 56:675-678.
28. Tannous-Khuri L, Talmage DA. Decreased cellular retinol-binding protein expression coincides with the loss of retinol responsiveness in rat cervical epithelial cells. Exp Cell Res. 1997;230:38-44.
29. Lafyatis R, Kim SJ, Angel P, Roberts AB, Sporn MB, Karin M, Wilder RL, Interleukin-1 stimulates and all-trans-retinoic acid inhibits collagenase gene expression through its 5′ activator protein-1-binding site. Mol Endocrinol. 1990;4:973-980.
30. Nicholson RC, Mader S, Nagpal S, Leid M, Rochette-Egly C, Chambon P. Negative regulation of the rat stromelysin gene promoter by retinoic acid is mediated by an API binding site. EMBO J. 1990;9:4443-4454.
31. van Giezen JJ, Boon GI, Jansen JW, Bouma BN. Retinoic acid enhances fibrinolytic activity in-vivo by enhancing tissue type plasminogen activator (t-PA) activity and inhibits venous thrombosis. Thromb Haemost. 1993;69:381-386.
32. Wang SY, LaRosa GJ, Gudas LJ. Molecular cloning of gene sequences transcriptionally regulated by retinoic acid and dibutyryl cyclic AMP in cultured mouse teratocarcinoma cells. Dev Biol. 1985;107:75-86.
33. Varani J, Mitra RS, Gibbs D, Phan SH, Dixit VM, Mitra R Jr, Wang T, Siebert KJ, Nickoloff BJ, Voorhees JJ. All-trans retinoic acid stimulates growth and extracellular matrix production in growth-inhibited cultured human skin fibroblasts. J Invest Dermatol. 1990;94:717-723.
34. Kato S, Sasaguri Y, Morimatsu M. Down-regulation in the production of matrix metalloproteinase 1 by human aortic intimai smooth muscle cells. Biochem Mol Biol Int. 1993;31:239-248.
35. Vassalli JD, Sappino AP, Belin D. The plasminogen activator/plasmin system. J Clin Invest. 1991;88:1067-1072.
36. Pepper MS, Montesano R, Mandriota SJ, Orci L, Vassalli JD. Angiogenesis: a paradigm for balanced extracellular proteolysis during cell migration and morphogenesis. Enzyme Protein. 1996;49:138-162.
37. Bulens F, Nelles L, Van den Panhuyzen N, Collen D. Stimulation by retinoids of tissue-type plasminogen activator secretion in cultured human endothelial cells: relations of structure to effect. J Cardiovasc Pharmacol. 1992;19:508-514.
38. Clowes AW, Clowes MM, Au YPT, Reidy MA, Belin D. Smooth muscle cells express urokinase during mitogenesis and tissue-type plasminogen activator during migration in injured rat carotid artery. Circ Res. 1990; 67:61-67.
39. Jackson CL, Raines EW, Ross R, Reidy MA. Role of endogenous platelet-derived growth factor in arterial smooth muscle cell migration after balloon catheter injury. Arterioscler Thromb. 1993;13:1218-1226.
40. Colbert MC, Kirby ML, Robbins J. Endogenous retinoic acid signaling colocalizes with advanced expression of the adult smooth muscle myosin heavy chain isoform during development of the ductus arteriosus. Circ Res. 1996;78:790-798.
41. Rudnicki MA, Sawtell NM, Reuhl KR, Berg R, Craig JC, Jardine K, Lessard JL, McBurney MW. Smooth muscle actin expression during P19 embryonal carcinoma differentiation in cell culture. 3 Cell Physiol. 1990; 142:89-98.
42. Blank RS, Swartz EA, Thompson MM, Olson EN, Owens GK. A retinoic acid-induced clonal cell line derived from multipotential P19 embryonal carcinoma cells expresses smooth muscle characteristics. Circ Res. 1995; 76:742-749.
43. Drab M, Haller H, Bychkov R, Erdmann B, Lindschau C, Haase H, Morano I, Luft FC, Wobus AM. From totipotent embryonic stem cells to spontaneously contracting smooth muscle cells: a retinoic acid and db-cAMP in vitro differentiation model. FASEB J. 1997;11:905-915.
44. Gollasch M, Haase H, Ried C, Lindschau C, Morano I, Luft FC, Haller H. L-type calcium channel expression depends on the differentiated state of vascular smooth muscle cells. FASEB J. 1998;12:593-601.
45. Husmann M, Hoffmann B, Stump DG, Chytil F, Pfahl M. A retinoic acid response element from the rat CRBPI promoter is activated by an RAR/RXR heterodimer. Biochem Biophys Res Commun. 1992;187: 1558-1564.
46. Giguere V. Retinoic acid receptors and cellular retinoid binding proteins: complex interplay in retinoid signaling. Endocr Rev. 1994;15:61-79.
47. Apfel C, Bauer F, Crettaz M, Forni L, Kamber M, Kaufmann F, LeMotte P, Pirson W, Klaus M. A retinoic acid receptor alpha antagonist selectively counteracts retinoic acid effects. Proc Natl Acad Sci USA. 1992; 89:7129-7133.
48. Pratt MA, Kralova J, McBurney MW. A dominant negative mutation of the alpha retinoic acid receptor gene in a retinoic acid-nonresponsive embryonal carcinoma cell. Mol Cell Biol. 1990;10:6445-6453.
49. Costa SL, McBurney MW. Dominant negative mutant of retinoic acid receptor alpha inhibits retinoic acid-induced P19 cell differentiation by binding to DNA. Exp Cell Res. 1996;225:35-43.
50. Kooistra T, Lansink M, Arts J, Sitter T, Toet K. Involvement of retinoic acid receptor a in the stimulation of tissue-type plasminogen-activator gene expression in human endothelial cells. Eur J Biochem. 1995;232: 425-432.
51. Miano JM, Kelly LA, Artacho CA, Nuckolls TA, Piantedosi R, Blaner WS. All-frans-retinoic acid reduces neointimal formation and promotes favorable geometric remodeling of the rat carotid artery after balloon withdrawal injury. Circulation. 1998;98:1219-1227.
52. David H, Hodak E, Lowe NJ. Adverse effects of retinoids. Med Toxicol Adverse Drug Exp. 1988;3:273-288.
53. Regazzi MB, Iacona I, Gervasutti C, Lazzarino M, Toma S. Clinical pharmacokinetics of tretinoin. Clin Pharmacokinet. 1997;32:382-402.